The Downregulation of MiR-182 is Associated with the Growth and Invasion of Osteosarcoma Cells Through the Regulation of TIAM1 Expression

Jun Hu,Guohua Lv,Shuguang Zhou,Yucheng Zhou,Bangxu Nie,Hong Duan,Yunfeng Zhang,Xiaofeng Yuan

DOI: https://doi.org/10.1371/journal.pone.0121175

IF: 3.7

2015-01-01

PLoS ONE

Abstract:BACKGROUND:Osteosarcoma is the most common primary bone malignancy in children and young adults. Increasing results suggest that discovery of microRNAs (miRNAs) might provide a novel therapeutical target for osteosarcoma.METHODS:MiR-182 expression level in osteosarcoma cell lines and tissues were assayed by qRT-PCR. MiRNA mimics or inhibitor were transfected for up-regulation or down-regulation of miR-182 expression. Cell function was assayed by CCK8, migration assay and invasion assay. The target genes of miR-182 were predicated by bioinformatics algorithm (TargetScan Human).RESULTS:MiR-182 was down-regulated in osteosarcoma tissues and cell lines. Overexpression of miR-182 inhibited tumor growth, migration and invasion. Subsequent investigation revealed that TIAM1 was a direct and functional target of miR-182 in osteosarcoma cells. Overexpression of miR-182 impaired TIAM1-induced inhibition of proliferation and invasion in osteosarcoma cells.CONCLUSIONS:Down-expression of miR-182 in osteosarcoma promoted tumor growth, migration and invasion by targeting TIAM1. MiR-182 might act as a tumor suppressor gene whose down-regulation contributes to the progression and metastasis of osteosarcoma, providing a potential therapy target for osteosarcoma patients.